Works in Cancer Chemotherapy & Pharmacology, 2009, Vol 63, Issue 6

Results: 28

A phase I study of Triapine in combination with doxorubicin in patients with advanced solid tumors.

Published in:

2009

By:

Schelman WR;
Morgan-Meadows S;
Marnocha R;
Lee F;
Eickhoff J;
Huang W;
Pomplun M;
Jiang Z;
Alberti D;
Kolesar JM;
Ivy P;
Wilding G;
Traynor AM;
Schelman, William R;
Morgan-Meadows, Sherry;
Marnocha, Rebecca;
Lee, Fred;
Eickhoff, Jens;
Huang, Wei;
Pomplun, Marcia

Publication type:

journal article

Life-threatening toxicities in a patient with UGT1A16/28 and SLCO1B115/15 genotypes after irinotecan-based chemotherapy.

Published in:

2009

By:

Takane H;
Kawamoto K;
Sasaki T;
Moriki K;
Kitano H;
Higuchi S;
Otsubo K;
Ieiri I;
Takane, Hiroshi;
Kawamoto, Katsuyuki;
Sasaki, Tomohiro;
Moriki, Kuniaki;
Moriki, Kazuyo;
Kitano, Hiroya;
Higuchi, Shun;
Otsubo, Kenji;
Ieiri, Ichiro

Publication type:

journal article

Isolated molecular relapse in FIP1L1-PDGFRalpha hypereosinophilic syndrome after discontinuation and single weekly dose of imatinib: need of quantitative molecular procedures to modulate imatinib dose.

Published in:

2009

By:

Breccia M;
Cilloni D;
Cannella L;
Stefanizzi C;
Tafuri A;
Fama A;
Santopietro M;
Saglio G;
Alimena G;
Breccia, Massimo;
Cilloni, Daniela;
Cannella, Laura;
Stefanizzi, Caterina;
Tafuri, Agostino;
Fama, Angelo;
Santopietro, Michelina;
Saglio, Giuseppe;
Alimena, Giuliana

Publication type:

journal article

Early severe toxicities after capecitabine intake: possible implication of a cytidine deaminase extensive metabolizer profile.

Published in:

Cancer Chemotherapy & Pharmacology, 2009, v. 63, n. 6, p. 1177, doi. 10.1007/s00280-008-0889-1

By:

Mercier, Cedric;
Dupuis, Charlotte;
Blesius, Aurore;
Fanciullino, Raphaelle;
Chen Guang Yang;
Padovani, Laetitia;
Giacometti, Sarah;
Frances, Nicolas;
Iliadis, Athanassios;
Duffaud, Florence;
Ciccolini, Joseph

Publication type:

Article

A phase I study of Triapine<sup>®</sup> in combination with doxorubicin in patients with advanced solid tumors.

Published in:

2009

By:

Schelman, William R.;
Morgan-Meadows, Sherry;
Marnocha, Rebecca;
Lee, Fred;
Eickhoff, Jens;
Wei Huang;
Pomplun, Marcia;
Zhisheng Jiang;
Alberti, Dona;
Kolesar, Jill M.;
Ivy, Percy;
Wilding, George;
Traynor, Anne M.

Publication type:

Report

Lenalidomide: in vitro evaluation of the metabolism and assessment of cytochrome P450 inhibition and induction.

Published in:

Cancer Chemotherapy & Pharmacology, 2009, v. 63, n. 6, p. 1171, doi. 10.1007/s00280-008-0867-7

By:

Kumar, Gondi;
Lau, Henry;
Laskin, Oscar

Publication type:

Article

Isolated molecular relapse in FIP1L1-PDGFRα hypereosinophilic syndrome after discontinuation and single weekly dose of imatinib: need of quantitative molecular procedures to modulate imatinib dose.

Published in:

Cancer Chemotherapy & Pharmacology, 2009, v. 63, n. 6, p. 1161, doi. 10.1007/s00280-008-0858-8

By:

Breccia, Massimo;
Cilloni, Daniela;
Cannella, Laura;
Stefanizzi, Caterina;
Tafuri, Agostino;
Fama, Angelo;
Santopietro, Michelina;
Saglio, Giuseppe;
Alimena, Giuliana

Publication type:

Article

Dual targeting of EGFR and HER-2 in colon cancer cell lines.

Published in:

Cancer Chemotherapy & Pharmacology, 2009, v. 63, n. 6, p. 973, doi. 10.1007/s00280-008-0820-9

By:

Giannopoulou, Efstathia;
Antonacopoulou, Anna;
Floratou, Konstantina;
Papavassiliou, Athanasios G.;
Kalofonos, Haralabos P.

Publication type:

Article

Lack of toxicity of a STAT3 decoy oligonucleotide.

Published in:

Cancer Chemotherapy & Pharmacology, 2009, v. 63, n. 6, p. 983, doi. 10.1007/s00280-008-0823-6

By:

Sen, Malabika;
Tosca, Patricia J.;
Zwayer, Christa;
Ryan, Michael J.;
Johnson, Jerry D.;
Knostman, Katherine A. B.;
Giclas, Patricia C.;
Peggins, James O.;
Tomaszewski, Joseph E.;
McMurray, Timothy P.;
Changyou Li;
Leibowitz, Michael S.;
Ferris, Robert L.;
Gooding, William E.;
Thomas, Sufi M.;
Johnson, Daniel E.;
Grandis, Jennifer R.

Publication type:

Article

Statins induce apoptosis in ovarian cancer cells through activation of JNK and enhancement of Bim expression.

Published in:

Cancer Chemotherapy & Pharmacology, 2009, v. 63, n. 6, p. 997, doi. 10.1007/s00280-008-0830-7

By:

Hongli Liu;
Shu-Ling Liang;
Kumar, Sheetal;
Weyman, Crystal M.;
Liu, Wendy;
Zhou, Aimin

Publication type:

Article

Studies of structure–activity relationship on plant polyphenol-induced suppression of human liver cancer cells.

Published in:

Cancer Chemotherapy & Pharmacology, 2009, v. 63, n. 6, p. 1007, doi. 10.1007/s00280-008-0802-y

By:

Loa, Jacky;
Chow, Pierce;
Kai Zhang

Publication type:

Article

Successful re-challenge with panitumumab in patients who developed hypersensitivity reactions to cetuximab: report of three cases and review of literature.

Published in:

Cancer Chemotherapy & Pharmacology, 2009, v. 63, n. 6, p. 1017, doi. 10.1007/s00280-008-0831-6

By:

Saif, Muhammad Wasif;
Peccerillo, J.;
Potter, Von

Publication type:

Article

Growth inhibitory activity of a novel lectin from Cliona varians against K562 human erythroleukemia cells.

Published in:

Cancer Chemotherapy & Pharmacology, 2009, v. 63, n. 6, p. 1023, doi. 10.1007/s00280-008-0825-4

By:

Queiroz, Alexandre F. S.;
Silva, Rodrigo A.;
Moura, Raniere M.;
Dreyfuss, Juliana L.;
Paredes-Gamero, Edgar J.;
Souza, Ana C. S.;
Tersariol, Ivarne L. S.;
Santos, Elizeu A.;
Nader, Helena B.;
Justo, Giselle Z.;
de Sales, Maurício P.

Publication type:

Article

Multiple-pool cell lifespan models for neutropenia to assess the population pharmacodynamics of unbound paclitaxel from two formulations in cancer patients.

Published in:

Cancer Chemotherapy & Pharmacology, 2009, v. 63, n. 6, p. 1035, doi. 10.1007/s00280-008-0828-1

By:

Bulitta, Jürgen B.;
Ping Zhao;
Arnold, Robert D.;
Kessler, Dean R.;
Daifuku, Richard;
Pratt, James;
Luciano, Gabriel;
Hanauske, Axel-R.;
Gelderblom, Hans;
Awada, Ahmad;
Jusko, William J.

Publication type:

Article

Mechanistic population pharmacokinetics of total and unbound paclitaxel for a new nanodroplet formulation versus Taxol in cancer patients.

Published in:

Cancer Chemotherapy & Pharmacology, 2009, v. 63, n. 6, p. 1049, doi. 10.1007/s00280-008-0827-2

By:

Bulitta, Jürgen B.;
Ping Zhao;
Arnold, Robert D.;
Kessler, Dean R.;
Daifuku, Richard;
Pratt, James;
Luciano, Gabriel;
Hanauske, Axel-R.;
Gelderblom, Hans;
Awada, Ahmad;
Jusko, William J.

Publication type:

Article

Phase I study of cetuximab, erlotinib, and bevacizumab in patients with advanced solid tumors.

Published in:

Cancer Chemotherapy & Pharmacology, 2009, v. 63, n. 6, p. 1065, doi. 10.1007/s00280-008-0811-x

By:

Chia-Chi Lin;
Calvo, Emiliano;
Papadopoulos, Kyriakos P.;
Patnaik, Amita;
Sarantopoulos, John;
Mita, Alain C.;
Preston, Glenn G.;
Mita, Monica M.;
Rodon, Jordi;
Mays, Theresa;
I.-Tien Yeh;
O'Rourke, Pat;
Takimoto, Chris H.;
Dancey, Janet E.;
Chen, Helen;
Tolcher, Anthony W.

Publication type:

Article

Phase I and pharmacokinetic study of mitomycin C and celecoxib as potential modulators of tumor resistance to irinotecan in patients with solid malignancies.

Published in:

Cancer Chemotherapy & Pharmacology, 2009, v. 63, n. 6, p. 1073, doi. 10.1007/s00280-008-0826-3

By:

Xu, Y.;
Kolesar, J. M.;
Schaaf, L. J.;
Drengler, R.;
Duan, W.;
Otterson, G.;
Shapiro, C.;
Kuhn, J.;
Villalona-Calero, M. A.

Publication type:

Article

A multi-center phase II study of S-1 plus paclitaxel as first-line therapy for patients with advanced or recurrent unresectable gastric cancer.

Published in:

Cancer Chemotherapy & Pharmacology, 2009, v. 63, n. 6, p. 1083, doi. 10.1007/s00280-008-0818-3

By:

Jae Jin Lee;
Si-Young Kim;
Hyun-Cheol Chung;
Kyung-Hee Lee;
Hong-Suk Song;
Won-Ki Kang;
Young-Seon Hong;
In-Sil Choi;
Young Yeul Lee;
In-Sook Woo;
Jin-Hyuk Choi

Publication type:

Article

Experiences and practical conclusions concerning temsirolimus use and adverse event management in advanced renal cell carcinoma within a compassionate use program in Germany.

Published in:

Cancer Chemotherapy & Pharmacology, 2009, v. 63, n. 6, p. 1097, doi. 10.1007/s00280-008-0835-2

By:

Gerullis, Holger;
Bergmann, Lothar;
Maute, Luise;
Eimer, Christoph;
Otto, Thomas

Publication type:

Article

Cisplatin and weekly docetaxel with concurrent thoracic radiotherapy for locally advanced stage III non-small-cell lung cancer.

Published in:

Cancer Chemotherapy & Pharmacology, 2009, v. 63, n. 6, p. 1091, doi. 10.1007/s00280-008-0837-0

By:

Nakamura, Masaru;
Koizumi, Tomonobu;
Hayasaka, Munehara;
Yasuo, Masanori;
Tsushima, Kenji;
Kubo, Keishi;
Gomi, Kotaro;
Shikama, Naoto

Publication type:

Article

Role of BCRP as a biomarker for predicting resistance to 5-fluorouracil in breast cancer.

Published in:

Cancer Chemotherapy & Pharmacology, 2009, v. 63, n. 6, p. 1103, doi. 10.1007/s00280-008-0838-z

By:

Jianhui Yuan;
Hui Lv;
Bo Peng;
Chengkun Wang;
Yu, Yanhui;
Zhimin He

Publication type:

Article

Multi-center phase II trial of chemo-radiotherapy with 5-fluorouracil, leucovorin and oxaliplatin in locally advanced esophageal cancer.

Published in:

Cancer Chemotherapy & Pharmacology, 2009, v. 63, n. 6, p. 1111, doi. 10.1007/s00280-008-0834-3

By:

Chiarion-Sileni, Vanna;
Innocente, Roberto;
Cavina, Raffaele;
Ruol, Alberto;
Corti, Luigi;
Pigozzo, Jacopo;
del Bianco, Paola;
Fumagalli, Uberto;
Santoro, Armando;
Ancona, Ermanno

Publication type:

Article

Diverse cross-resistance phenotype to ET-743 and PM00104 in multi-drug resistant cell lines.

Published in:

Cancer Chemotherapy & Pharmacology, 2009, v. 63, n. 6, p. 1121, doi. 10.1007/s00280-008-0843-2

By:

Zhenfeng Duan;
Choy, Edwin;
Jimeno, Jose Maria;
del Maria Cuevas, Carmen;
Mankin, Henry J.;
Hornicek, Francis J.

Publication type:

Article

Cytotoxic diarylheptanoid induces cell cycle arrest and apoptosis via increasing ATF3 and stabilizing p53 in SH-SY5Y cells.

Published in:

Cancer Chemotherapy & Pharmacology, 2009, v. 63, n. 6, p. 1131, doi. 10.1007/s00280-008-0832-5

By:

Ze Tian;
Ning An;
Bin Zhou;
Peigen Xiao;
Kohane, Isaac;
Wu, Erxi

Publication type:

Article

Irinotecan monotherapy as second-line treatment in advanced pancreatic cancer.

Published in:

Cancer Chemotherapy & Pharmacology, 2009, v. 63, n. 6, p. 1141, doi. 10.1007/s00280-008-0839-y

By:

Seong Yoon Yi;
Park, Young Suk;
Hyo Song Kim;
Hyun Jung Jun;
Kyoung Ha Kim;
Myung Hee Chang;
Park, Min Jae;
Ji Eun Uhm;
Jeeyun Lee;
Park, Se Hoon;
Park, Joon Oh;
Jong Kyun Lee;
Kyu Taek Lee;
Ho Yeong Lim;
Won Ki Kang

Publication type:

Article

Extended survival of a HER-2-positive metastatic breast cancer patient with brain metastases also treated with intrathecal trastuzumab.

Published in:

Cancer Chemotherapy & Pharmacology, 2009, v. 63, n. 6, p. 1157, doi. 10.1007/s00280-008-0859-7

By:

Colozza, Mariantonietta;
Minenza, Elisa;
Gori, Stefania;
Fenocchio, Daniela;
Paolucci, Cristina;
Aristei, Cynthia;
Floridi, Piero

Publication type:

Article

Life-threatening toxicities in a patient with UGT1A1* 6/* 28 and SLCO1B1* 15/* 15 genotypes after irinotecan-based chemotherapy.

Published in:

Cancer Chemotherapy & Pharmacology, 2009, v. 63, n. 6, p. 1165, doi. 10.1007/s00280-008-0864-x

By:

Takane, Hiroshi;
Kawamoto, Katsuyuki;
Sasaki, Tomohiro;
Moriki, Kuniaki;
Moriki, Kazuyo;
Kitano, Hiroya;
Higuchi, Shun;
Otsubo, Kenji;
Ieiri, Ichiro

Publication type:

Article

5-FU pretreatment potentiates cisplatin-induced apoptosis through up-regulation of thrombospondin-1 in head and neck squamous cell carcinomas.

Published in:

2009

By:

Bei Xu;
Peng Liu

Publication type:

Letter